本页面由Tiger Trade Technology Pte. Ltd.提供服务

Artiva Biotherapeutics, Inc.

5.23
-0.1400-2.61%
成交量:7.80万
成交额:41.11万
市值:1.29亿
市盈率:-1.52
高:5.45
开:5.35
低:5.16
收:5.37
52周最高:7.75
52周最低:1.47
股本:2,471.67万
流通股本:538.17万
量比:0.61
换手率:1.45%
股息:- -
股息率:- -
每股收益(TTM):-3.4309
每股收益(LYR):-3.4309
净资产收益率:-56.55%
总资产收益率:-32.97%
市净率:1.18
市盈率(LYR):-1.52

数据加载中...

公司资料

公司名字:
Artiva Biotherapeutics, Inc.
交易所:
NASDAQ
成立时间:
2019
员工人数:
104
公司地址:
5505 Morehouse Drive,Suite 100,San Diego,California,United States
邮编:
92121
电话:
传真:
- -
简介:
Artiva Biotherapeutics, Inc.于2019年2月14日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,专注于为患有破坏性自身免疫性疾病和癌症的患者开发基于自然杀伤(NK)细胞的疗法。

董事

名称
职位
Fred Aslan
President,Chief Executive Officer and Director
Brian Daniels
Chairperson
Alison Moore
Director
Daniel Baker
Director
Diego Miralles
Director
Elaine Sorg
Director
Elizabeth Hougen
Director
Laura Stoppel
Director

股东

名称
职位
Fred Aslan
President,Chief Executive Officer and Director
Jennifer Bush
Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer
Heather Raymon
Senior Vice President of Research and Early Development
Neha Krishnamohan
Chief Financial Officer and Executive Vice President of Corporate Development
Thad Huston
Chief Financial Officer,Principal Accounting Officer and Principal Financial Officer
Christopher P. Horan
Chief Technical Operations Officer
Subhashis Banerjee
Chief Medical Officer